HIGH-RISK

Clinical trials for HIGH-RISK explained in plain language.

Never miss a new study

Get alerted when new HIGH-RISK trials appear

Sign up with your email to follow new studies for HIGH-RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug combo aims to keep High-Risk leukemia in remission before transplant

Disease control Not yet recruiting

This study tests whether a combination of venetoclax and azacitidine works better than standard chemotherapy as a short-term treatment before a stem cell transplant in adults with high-risk acute myeloid leukemia (AML) who are already in remission. About 216 participants will be …

Matched conditions: HIGH-RISK

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Apr 26, 2026 20:01 UTC

HIGH-RISK

Get alerted when new HIGH-RISK trials appear

New drug combo aims to keep High-Risk leukemia in remission before transplant